Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mio Namba

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Journal of Dermatology : EJD|September 20, 2011
Sorafenib-induced erythema multiforme: three casesMio Namba, Yuichiro Tsunemi, Makoto Kawashima
International Journal of Dermatology|March 16, 2012
Multiple basal cell carcinomas in an atomic bomb survivorMio Namba, Nobukazu Hayashi, Yuko Takenaka, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 14, 2017
Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic strokeTatsuya Fukuta, Tomohiro Asai, Yosuke Yanagida, et al.
Biochemical and Biophysical Research Communications|August 22, 2020
Release rate is a key variable affecting the therapeutic effectiveness of liposomal fasudil for the treatment of cerebral ischemia/reperfusion injuryYosuke Yanagida, Mio Namba, Tatsuya Fukuta, et al.
International Journal of Pharmaceutics|April 25, 2016
Neuroprotection against cerebral ischemia/reperfusion injury by intravenous administration of liposomal fasudilTatsuya Fukuta, Tomohiro Asai, Akihiko Sato, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Journal of Dermatology : EJD|September 20, 2011
Sorafenib-induced erythema multiforme: three casesMio Namba, Yuichiro Tsunemi, Makoto Kawashima
International Journal of Dermatology|March 16, 2012
Multiple basal cell carcinomas in an atomic bomb survivorMio Namba, Nobukazu Hayashi, Yuko Takenaka, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 14, 2017
Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic strokeTatsuya Fukuta, Tomohiro Asai, Yosuke Yanagida, et al.
Biochemical and Biophysical Research Communications|August 22, 2020
Release rate is a key variable affecting the therapeutic effectiveness of liposomal fasudil for the treatment of cerebral ischemia/reperfusion injuryYosuke Yanagida, Mio Namba, Tatsuya Fukuta, et al.
International Journal of Pharmaceutics|April 25, 2016
Neuroprotection against cerebral ischemia/reperfusion injury by intravenous administration of liposomal fasudilTatsuya Fukuta, Tomohiro Asai, Akihiko Sato, et al.
Pageof 1